Carey R M
Department of Medicine, University of Virginia School of Medicine, Charlottesville, USA.
Hypertension. 2001 Sep;38(3):297-302. doi: 10.1161/hy0901.096422.
All of the components of a complete dopamine system are present within the kidney, where dopamine acts as a paracrine substance in the control of sodium excretion. Dopamine receptors can be divided into D(1)-like (D(1) and D(5)) receptors that stimulate adenylyl cyclase and D(2)-like (D(2), D(3), and D(4)) receptors that inhibit adenylyl cyclase. All 5 receptor subtypes are expressed in the kidney, albeit in low copy. Dopamine is synthesized extraneuronally in proximal tubule cells, exported from these cells largely into the tubule lumen, and interacts with D(1)-like receptors to inhibit the Na(+)-H(+) exchanger and Na(+),K(+)-ATPase, decreasing tubule sodium reabsorption. During moderate sodium surfeit, dopamine tone at D(1)-like receptors accounts for approximately 50% of sodium excretion. In experimental and human hypertension, 2 renal dopaminergic defects have been described: (1) decreased renal generation of dopamine and (2) a D(1) receptor-G protein coupling defect. Both defects lead to renal sodium retention, and each may play an important role in the pathophysiology of essential hypertension.
完整的多巴胺系统的所有组成部分都存在于肾脏中,在那里多巴胺作为一种旁分泌物质参与钠排泄的调控。多巴胺受体可分为刺激腺苷酸环化酶的D(1)样(D(1)和D(5))受体以及抑制腺苷酸环化酶的D(2)样(D(2)、D(3)和D(4))受体。所有5种受体亚型在肾脏中均有表达,尽管拷贝数较低。多巴胺在近端小管细胞中进行细胞外合成,从这些细胞大量分泌到小管腔中,并与D(1)样受体相互作用,抑制Na(+)-H(+)交换体和Na(+),K(+)-ATP酶,减少小管对钠的重吸收。在适度钠过剩期间,D(1)样受体处的多巴胺张力约占钠排泄量的50%。在实验性高血压和人类高血压中,已描述了两种肾脏多巴胺能缺陷:(1)肾脏多巴胺生成减少和(2)D(1)受体 - G蛋白偶联缺陷。这两种缺陷都会导致肾脏钠潴留,且每种缺陷可能在原发性高血压的病理生理学中起重要作用。